FI67543C - Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin - Google Patents

Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin Download PDF

Info

Publication number
FI67543C
FI67543C FI810288A FI810288A FI67543C FI 67543 C FI67543 C FI 67543C FI 810288 A FI810288 A FI 810288A FI 810288 A FI810288 A FI 810288A FI 67543 C FI67543 C FI 67543C
Authority
FI
Finland
Prior art keywords
compound
formula
imidazoline
benzodioxanyl
presynaptic
Prior art date
Application number
FI810288A
Other languages
English (en)
Finnish (fi)
Other versions
FI810288L (fi
FI67543B (fi
Inventor
Christopher Bourne Chapleo
Peter Leslie Myers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of FI810288L publication Critical patent/FI810288L/fi
Application granted granted Critical
Publication of FI67543B publication Critical patent/FI67543B/fi
Publication of FI67543C publication Critical patent/FI67543C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI810288A 1980-02-04 1981-02-02 Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin FI67543C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8003636 1980-02-04
GB8003636 1980-02-04

Publications (3)

Publication Number Publication Date
FI810288L FI810288L (fi) 1981-08-05
FI67543B FI67543B (fi) 1984-12-31
FI67543C true FI67543C (fi) 1985-04-10

Family

ID=10511105

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810288A FI67543C (fi) 1980-02-04 1981-02-02 Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin

Country Status (26)

Country Link
US (1) US4818764A (da)
EP (1) EP0033655B1 (da)
JP (1) JPS56122378A (da)
AR (1) AR225794A1 (da)
AT (1) ATE7228T1 (da)
AU (1) AU535320B2 (da)
CA (1) CA1156241A (da)
CS (1) CS254956B2 (da)
DD (1) DD155991A5 (da)
DE (1) DE3163256D1 (da)
DK (1) DK160092C (da)
ES (1) ES499034A0 (da)
FI (1) FI67543C (da)
GB (1) GB2068376B (da)
GR (1) GR73853B (da)
HU (1) HU187295B (da)
IE (1) IE51736B1 (da)
IL (1) IL62039A (da)
NO (1) NO154882C (da)
NZ (1) NZ196162A (da)
PH (1) PH16249A (da)
PL (1) PL128368B1 (da)
PT (1) PT72435B (da)
SU (1) SU1128837A3 (da)
ZA (1) ZA81666B (da)
ZW (1) ZW2381A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2527208B1 (fr) * 1982-05-19 1985-07-19 Inst Nat Sante Rech Med Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2d-2 imidazoline, leur preparation et leur application en therapeutique
ATE23337T1 (de) * 1982-12-23 1986-11-15 Ici America Inc Chromanverbindungen.
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
US5240930A (en) * 1987-09-02 1993-08-31 National Research Development Corporation Pharmaceutical compositions for treatment of depression and low blood pressure
GB8720600D0 (en) * 1987-09-02 1987-10-07 Saad Al Damluji Pharmaceutical compositions
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite
WO2001064223A1 (en) * 2000-02-29 2001-09-07 Merck Frosst Canada & Co. Method for treating or preventing depression
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
FR2861299B1 (fr) * 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
WO2023159145A1 (en) * 2022-02-16 2023-08-24 Terran Biosciences, Inc. Deuterated idazoxan and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641601A (en) * 1950-11-24 1953-06-09 Hoffmann La Roche Furans and method of preparation
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
JPS5276346A (en) * 1975-12-22 1977-06-27 Sumitomo Bakelite Co Ltd Epoxy resin adhesive composition
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4301171A (en) * 1980-12-03 1981-11-17 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)benzimidazoles useful as anti-depressants
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Also Published As

Publication number Publication date
IL62039A (en) 1985-01-31
JPS56122378A (en) 1981-09-25
NO810351L (no) 1981-08-05
PT72435A (en) 1981-03-01
DK160092B (da) 1991-01-28
ATE7228T1 (de) 1984-05-15
NO154882C (no) 1987-01-07
PH16249A (en) 1983-08-16
EP0033655B1 (en) 1984-04-25
IE51736B1 (en) 1987-03-18
DD155991A5 (de) 1982-07-21
ES8202553A1 (es) 1982-02-01
PL229488A1 (da) 1981-10-16
AU6675881A (en) 1981-08-13
IE810199L (en) 1981-08-04
CA1156241A (en) 1983-11-01
JPH0231077B2 (da) 1990-07-11
AU535320B2 (en) 1984-03-15
AR225794A1 (es) 1982-04-30
CS254956B2 (en) 1988-02-15
EP0033655A3 (en) 1981-11-25
GB2068376B (en) 1983-06-22
DK45081A (da) 1981-08-05
FI810288L (fi) 1981-08-05
EP0033655A2 (en) 1981-08-12
GB2068376A (en) 1981-08-12
NZ196162A (en) 1983-06-17
ZW2381A1 (en) 1981-06-24
SU1128837A3 (ru) 1984-12-07
PT72435B (pt) 1982-01-29
HU187295B (en) 1985-12-28
DE3163256D1 (en) 1984-05-30
GR73853B (da) 1984-05-07
ZA81666B (en) 1982-04-28
US4818764A (en) 1989-04-04
FI67543B (fi) 1984-12-31
ES499034A0 (es) 1982-02-01
DK160092C (da) 1991-06-24
CS73881A2 (en) 1987-07-16
NO154882B (no) 1986-09-29
PL128368B1 (en) 1984-01-31
IL62039A0 (en) 1981-03-31

Similar Documents

Publication Publication Date Title
FI67543C (fi) Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin
SU1184443A3 (ru) Способ получени производных тиазола (его варианты)
BG60762B2 (bg) Заместени имидазолови производни и тяхното получаване и приложение
CS247073B2 (en) Production method of 2-substituted 4-amino-6,7-dimethoxyghinolins
US5498623A (en) 4(5) substituted imidazoles and their preparation and use
IE51551B1 (en) Isoquinoline derivatives,process for their preparation and pharmaceutical formulations containing them and their use
NO178968B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater
EP0047531B1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
US5925665A (en) Imidazoline compounds
US5342960A (en) Azomethines agonist compounds of the histamine H3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of the said receptor and preparation process
FI67544C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefullt imidazolinderivat
SU1217257A3 (ru) Способ получени производных имидазолина или их нетоксичных солей
Caroon et al. Structure-activity relationships for 2-substituted imidazoles as. alpha. 2-adrenoceptor antagonists
AU2401492A (en) Spirocyclic benzopyran imidazolines
KR20100096262A (ko) 신규한 이미다졸리닐메틸 아릴 설폰아미드
KR20100096261A (ko) 신규한 이미다졸리닐메틸 아릴 설폰아미드
SU1398771A3 (ru) Способ получени замещенных бензамидов
US4497818A (en) 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antihypertensives and platelet aggregation inhibitors
HU189726B (en) Process for preparing trans-4ar-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-1h/2h/-pyrazolo/3,4-g/quinoline
EP0108766A1 (fr) Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2delta-2 imidazoline, leur preparation et leur application en therapeutique
IE52074B1 (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: PIERRE FABRE MEDICAMENT SA

MM Patent lapsed

Owner name: PIERRE FABRE MEDICAMENT SA